News Detail
New Delhi, 3 Jan 2025 (IANS) Immuno-oncology (IO) drugs or cancer therapeutics represent one of the most promising areas of medical innovation in the next five years, according to a report on Friday.
The report by GlobalData, a data and analytics company, base......
View Details
Source : IANS
Immuno-oncology (IO) drugs
cancer therapeutics
medical innovation
GlobalData
Urte Jakimaviciute
Senior Director of Market Research and Strategic Intelligence in the healthcare division at GlobalData
Related News
- First ayurvedic diagnostic device 'Nadi Tarangini', gets CDSCO nod (06-01-2025)
- ITRI Unveils Advanced Smart Medical Technology at CES 2025 (06-01-2025)
- MTal Gears up for MedTekon (06-01-2025)
- Medical store operator arrested with drug Injections and Tablets (06-01-2025)
- CDRI research a ray of hope for triple negative breast cancer patients (06-01-2025)
- CDSCO releases draft standard evaluation protocols for issuing license for IVDs (06-01-2025)
- Complaints filed with FDA and CMO against Solapur Ayush manufacturer; owner refutes allegations (05-01-2025)
- MP FDA forms joint team with Centre to ensure revised Schedule M compliance in pharma cos (05-01-2025)
- Draft notification for extension of Schedule M published for comments (04-01-2025)
- Illegal medical shop busted in Hyderabad (04-01-2025)